BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38748286)

  • 101. 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.
    Kawai N; Miyake K; Yamamoto Y; Nishiyama Y; Tamiya T
    Biomed Res Int; 2013; 2013():247152. PubMed ID: 23844359
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Comparison of diffusion-weighted MRI and [
    Morakote W; Baratto L; Ramasamy SK; Adams LC; Liang T; Sarrami AH; Daldrup-Link HE
    Eur Radiol; 2024 Jan; 34(1):643-653. PubMed ID: 37542653
    [TBL] [Abstract][Full Text] [Related]  

  • 103.
    Husby T; Johannessen K; Berntsen EM; Johansen H; Giskeødegård GF; Karlberg A; Fagerli UM; Eikenes L
    EJNMMI Rep; 2024 Jan; 8(1):2. PubMed ID: 38748286
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Phase IIa clinical study of [
    Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
    Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
    [TBL] [Abstract][Full Text] [Related]  

  • 105. [18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network.
    Rozenblum L; Galanaud D; Houillier C; Soussain C; Baptiste A; Belin L; Edeline V; Naggara P; Soret M; Causse-Lemercier V; Willems L; Choquet S; Ursu R; Hoang-Xuan K; Kas A
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3684-3696. PubMed ID: 37462774
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Diagnostic accuracy of anti-3-[
    Karlberg A; Pedersen LK; Vindstad BE; Skjulsvik AJ; Johansen H; Solheim O; Skogen K; Kvistad KA; Bogsrud TV; Myrmel KS; Giskeødegård GF; Ingebrigtsen T; Berntsen EM; Eikenes L
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):496-509. PubMed ID: 37776502
    [TBL] [Abstract][Full Text] [Related]  

  • 107. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Diagnostic Value of 18 F-FACBC PET/MRI in Brain Metastases.
    Øen SK; Johannessen K; Pedersen LK; Berntsen EM; Totland JA; Johansen H; Bogsrud TV; Solheim TS; Karlberg A; Eikenes L
    Clin Nucl Med; 2022 Dec; 47(12):1030-1039. PubMed ID: 36241129
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
    Ferreri AJM; Cwynarski K; Pulczynski E; Fox CP; Schorb E; Celico C; Falautano M; Nonis A; La Rosée P; Binder M; Fabbri A; Ilariucci F; Krampera M; Roth A; Hemmaway C; Johnson PW; Linton KM; Pukrop T; Gørløv JS; Balzarotti M; Hess G; Keller U; Stilgenbauer S; Panse J; Tucci A; Orsucci L; Pisani F; Zanni M; Krause SW; Schmoll HJ; Hertenstein B; Rummel M; Smith J; Thurner L; Cabras G; Pennese E; Ponzoni M; Deckert M; Politi LS; Finke J; Ferranti A; Cozens K; Burger E; Ielmini N; Cavalli F; Zucca E; Illerhaus G;
    Leukemia; 2022 Jul; 36(7):1870-1878. PubMed ID: 35562406
    [TBL] [Abstract][Full Text] [Related]  

  • 110. First-in-Man Noninvasive Initial Diagnostic Approach of Primary CNS Lymphoma Versus Glioblastoma Using PET With 18 F-Fludarabine and l -[methyl- 11 C]Methionine.
    Postnov A; Toutain J; Pronin I; Valable S; Gourand F; Kalaeva D; Vikhrova N; Pyzhik E; Guillouet S; Kobyakov G; Khokholova E; Pitskhelauri D; Usachev D; Maryashev S; Rizhova M; Potapov A; Derlon JM
    Clin Nucl Med; 2022 Aug; 47(8):699-706. PubMed ID: 35485864
    [TBL] [Abstract][Full Text] [Related]  

  • 111.
    Johannessen K; Berntsen EM; Johansen H; Solheim TS; Karlberg A; Eikenes L
    Eur J Hybrid Imaging; 2021 Apr; 5(1):7. PubMed ID: 34181107
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
    Barajas RF; Politi LS; Anzalone N; Schöder H; Fox CP; Boxerman JL; Kaufmann TJ; Quarles CC; Ellingson BM; Auer D; Andronesi OC; Ferreri AJM; Mrugala MM; Grommes C; Neuwelt EA; Ambady P; Rubenstein JL; Illerhaus G; Nagane M; Batchelor TT; Hu LS
    Neuro Oncol; 2021 Jul; 23(7):1056-1071. PubMed ID: 33560416
    [TBL] [Abstract][Full Text] [Related]  

  • 113. [
    Parent EE; Patel D; Nye JA; Li Z; Olson JJ; Schuster DM; Goodman MM
    EJNMMI Res; 2020 Dec; 10(1):148. PubMed ID: 33284388
    [TBL] [Abstract][Full Text] [Related]  

  • 114. High 18F-FDOPA PET Uptake in Primary Central Nervous System Lymphoma.
    Salgues B; Kaphan E; Molines E; Brun G; Guedj E
    Clin Nucl Med; 2021 Jan; 46(1):e59-e60. PubMed ID: 32956128
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Synthesis, Radiolabeling, and Biological Evaluation of the
    Pickel TC; Voll RJ; Yu W; Wang Z; Nye JA; Bacsa J; Olson JJ; Liebeskind LS; Goodman MM
    J Med Chem; 2020 Oct; 63(20):12008-12022. PubMed ID: 32946235
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.